Publikation

ATG-Fresenius or daclizumab induction therapy in immunologically high risk kidney recipients: a prospective randomized pilot trial

Wissenschaftlicher Artikel/Review - 01.01.2008

Kim Min Jeong, Tsinalis Dimitrios, Franz Stefan, Binet Françoise-Isabelle, Gürke Lorenz, Mihatsch Michael J, Steiger Jürg, Thiel Gilbert, Dickenmann Michael